Trial intelligence / Profile preview

Switching From Sildenafil to Tadalafil in ED

NCT00547287Phase 3Completed

Sponsor
Eli Lilly and Company
Start
Nov 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tadalafil in erectile dysfunction (ED), sponsored by Eli Lilly and Company. Started Nov 2002; status: completed.

02

Drugs

tadalafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00547287.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00547287.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call